Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Rapid Impact Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Metabolism Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Spotlight on Genomic Analysis of Rare and Understudied Cancers
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Cancer Research
Molecular Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Rapid Impact Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Metabolism Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Spotlight on Genomic Analysis of Rare and Understudied Cancers
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Highlights

Highlights of This Issue

DOI:  Published January 2016
  • Article
  • Info & Metrics
  • PDF
Loading

Mitogenic Hedgehog Signaling and Mitochondria Form

Malhotra et al. Page 114

Sonic hedgehog (Shh) signaling is closely coupled with bioenergetics of medulloblastoma. In this study, effects of Shh on mitochondrial dynamics were investigated. Exposure of cerebellar granule neuron precursors, the cells-of-origin for medulloblastoma, to Shh, their obligate mitogen, altered mitochondria structurally, blocking their fusion through suppression of mitofusins. This resulted in reduced mitochondrial membrane potential and overall ATP production. Similar findings were observed in tumor tissue and mouse medulloblastoma cells. Ectopically expressed mitofusins rescued the metabolic profile of tumor cells to that of non-transformed, non-proliferating cells. Regulation of mitochondrial dynamics by Shh represents a potential avenue to generate improved medulloblastoma therapeutics.

BRCA2 and RAD51 Promote Oncolytic Adenovirus Activity

Tookman et al. Page 44

Oncolytic adenoviruses hold therapeutic promise; however, their interactions with stress response pathways are still being studied. Tookman and colleagues investigated the interplay between oncolytic adenovirus and the Homologous Recombination (HR) pathway of DNA double strand break repair in high grade serous ovarian cancer (HGSOC). Half of HGSOC retained normal HR function, which is associated with poor response to chemotherapy and reduced overall survival. In addition, the data indicate that adenovirus type 5 vectors utilize HR components to enhance their own replication, and that both BRCA2 and RAD51 localize to virus replication centers in the infected cell nucleus. Thus, oncolytic adenoviral therapy may specifically benefit patients whose tumors have an intact HR pathway.

p53 Activity Dominates that of p73 Caused by Mdm4 Loss

Tashakori et al. Page 56

Mdm4 negatively regulates p53 activity in embryogenesis and tumorigenesis. p73 is a transcription factor with structural and functional homology to p53. Unlike p53, this tumor suppressor lacks mutations in most cancers. Mdm4 has higher affinity for p73 than p53, which suggests a mechanism for p73 inactivation in cancer development. In this study, p73 loss did not rescue any Mdm4-deficient phenotypes as did p53 deletion, despite evidence for p73-specific transcriptional activity. In addition, Mdm4 overexpression and p73 heterozygosity did not synergize in tumor development demonstrating that the Mdm4-p73 axis cannot override the dominant role of p53 in development and tumorigenesis.

Periostin-ITGB3 Signaling Maintains Breast CSCs

Lambert et al. Page 103

Basal-like breast cancer is an aggressive subtype of breast cancer that is often enriched with cancer stem cells, which contribute to metastasis, resistance to chemotherapy, and disease recurrence. Here, Lambert and colleagues find that periostin, a matricellular protein, is secreted by basal-like breast cancer cells and mechanistically acts through integrin β3 to control the production of key cytokines that regulate the stem cell state. This work highlights the idea that tumor cell-derived factors allow basal-like breast cancer cells to establish their own functional niche, which acts to maintain a population of cancer stem cells.

  • ©2016 American Association for Cancer Research.
PreviousNext
Back to top
Molecular Cancer Research: 14 (1)
January 2016
Volume 14, Issue 1
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Highlights of This Issue
(Your Name) has forwarded a page to you from Molecular Cancer Research
(Your Name) thought you would be interested in this article in Molecular Cancer Research.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Highlights of This Issue
Mol Cancer Res January 1 2016 (14) (1) 1;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Highlights of This Issue
Mol Cancer Res January 1 2016 (14) (1) 1;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Mitogenic Hedgehog Signaling and Mitochondria Form
    • BRCA2 and RAD51 Promote Oncolytic Adenovirus Activity
    • p53 Activity Dominates that of p73 Caused by Mdm4 Loss
    • Periostin-ITGB3 Signaling Maintains Breast CSCs
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Selected Articles from This Issue
  • Selected Articles from This Issue
  • Selected Articles from This Issue
Show more Highlights
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Rapid Impact Archive
  • Meeting Abstracts

Information for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About MCR

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Molecular Cancer Research
eISSN: 1557-3125
ISSN: 1541-7786

Advertisement